[Asia Economy Reporter Minji Lee] SK Biopharm announced on the 20th that it has signed a pharmaceutical supply contract worth 28,860,100,000 KRW with SK Life Science. This amounts to 110% of its recent sales revenue.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
